ACAD vs REGN: Which Stock is Better?
Side-by-side comparison of ACADIA Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026
ACAD
ACADIA Pharmaceuticals Inc
—
REGN
Regeneron Pharmaceuticals Inc
$662.73
Key Metrics Comparison
| Metric | ACAD | REGN | Winner |
|---|---|---|---|
| Market Cap | $3.51B | $59.10B | REGN |
| P/E Ratio | 15.29 | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ACAD
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACAD or REGN a better investment?
Comparing ACAD and REGN: ACADIA Pharmaceuticals Inc has a market cap of $3.51B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACAD and REGN?
ACAD (ACADIA Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACAD or REGN?
Based on P/E ratios, REGN trades at a lower multiple (13.9x vs 15.3x).
Which is growing faster: ACAD or REGN?
Both ACAD and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ACAD or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ACAD or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $3.51B for ACAD.
Should I buy ACAD or REGN in 2026?
Both ACAD and REGN have investment merit. ACAD trades at $N/A while REGN trades at $662.73. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACAD and REGN stock?
Key differences: Market Cap ($3.51B vs $59.10B), P/E Ratio (15.3x vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ACAD or REGN in 2026?
The choice between ACAD and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ACAD and REGN?
ACAD (ACADIA Pharmaceuticals Inc) has a market cap of $3.51B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.